| HOME >> BIOLOGY >> TECHNOLOGY |
Digirad Recognized for Imaging Platform and Successful Mobile Imaging
Services Network
POWAY, Calif., Feb. 6 /PRNewswire-FirstCall/ -- Digirad Corporation (Nasdaq: DRAD), a leading provider of medical diagnostic imaging systems and services to physicians' offices, hospitals and imaging centers, today announced it is the recipient of Frost & Sullivan's 2007 North American Nuclear Medicine Equipment Product Line Strategy Award.
Travis Chong, research analyst for Frost & Sullivan, remarked that the award recognizes Digirad for its strategy in developing a common dedicated SPECT camera platform based on solid-state technology that offers single, dual and triple-head configurations that can accommodate physicians' workflow needs; for example, using a three-head XPO system for faster image processing and higher throughput of patients. The XPO systems can handle patients weighing up to 500 pounds and may also be configured for fixed or mobile operation, with the mobile configuration providing the ideal solution to service multiple sites enhancing asset utilization or developing outreach activities to increase revenues.
"With the integration of the XPO feature into its entire Cardius line, Digirad has developed a scalable system platform designed to accommodate consumer needs as their operations develop over time," said Chong.
The award also recognizes Digirad's successful establishment of a growing network that offers in-office mobile imaging services through its Digirad Imaging Solutions (DIS) division. Digirad was the first to develop and commercialize solid-state nuclear imaging systems and, based on growing demand for diagnostic imaging services, extended its operations by offering mobile imaging services, which now comprise more than 70 percent of annual revenues.
Digirad Chief Executive Mark Casner remarked: "We are quite pleased to be this year's recipient and appreciate the recognition by Frost & Sullivan for not only being the pioneer and leader in solid-state imaging technology but also for increasing access to this industry-leading technology through our XPO dedicated cardiac SPECT systems and mobile imaging services businesses. Demand for imaging services continues to rise while physicians are, at the same time, facing economic and other barriers to purchasing equipment, retaining licensed personnel and meeting accreditation requirements."
The Frost & Sullivan Award for Product Line Strategy is presented each year to the company that has demonstrated the greatest insight into the needs and demands of its market and customers. The recipient has optimized its business line by leveraging products with the various price, performance, and feature points required by one or more of its market segments.
To select the award recipient, Frost & Sullivan analysts track end-user requirements and market dynamics. The process includes interviews with suppliers, end-users, and industry experts, and the business lines are compared with customer-base demands, with the top-ranking provider receiving the award.
About Frost & Sullivan
Frost & Sullivan, the Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.frost.com.
About Digirad Corporation
Digirad provides diagnostic nuclear and ultrasound imaging systems and services to physicians' offices, hospitals and imaging centers for cardiac, vascular, and general imaging applications. Digirad's Cardius XPO line of nuclear imaging cameras use patented solid-state technology and unique multi (single, dual, triple) head design for superior performance and advanced features for sharper digital images, faster processing, compact size, lighter weight for portability, ability to handle patients up to 500 pounds, and improved patient comfort compared to standard nuclear cameras. Digirad's 2020tc general-purpose nuclear imager has a small footprint and may also be configured for fixed or mobile use to supplement primary imaging. Digirad's installed base of equipment exceeds 450 systems; in addition, a mobile fleet of more than 120 nuclear and ultrasound imaging systems is being used in 22 states, primarily in the eastern, midwestern and southwestern United States. For more information, please visit http://www.digirad.com. Digirad(R), Digirad Imaging Solutions(R), and Cardius(R) are registered trademarks of Digirad Corporation.
'/>"/>
| SOURCE Digirad Corporation Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Finkelstein Thompson LLP Announces Filing of Securities Fraud Class Action Against CellCyte Genetics Corporation
2. DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results
3. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
4. CV Therapeutics and Medlogics Device Corporation Sign Licensing Agreement for CVTs Innovative Stent Coating Technology
5. DURECT Corporation Invites You to Join Its Fourth Quarter 2007 Earnings Conference Call
6. Baxa Corporation Launches New Web Site
7. CuraGen Corporation Receives Notification from NASDAQ
8. Healionics Corporation Completes Series A Financing
9. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2008
10. China Bionanometer Industries Corporation Announces Record Second Quarter 2007 Results
11. Hagens Berman Sobol Shapiro: Lawsuit Filed Against CellCyte Genetics Corporation
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |